Skip to main content
ES
v1.2
Log in
P

Pfizer

PFIZERNSE
₹3,814+3.20 (+0.08%)as of 2026-10-16
Market Cap
₹17,440Cr.
P/E Ratio
22.7
P/B Ratio
4.15
EPS (TTM)
₹168.02
Day Range
₹3,744 – ₹3,840
Div Yield
1.85%
ROCE
24.1%
ROE
18%
52W Low: ₹3,73152W High: ₹5,446
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 1.0% a year over three years.
  • Debt is 0.02× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Pfizer — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
6/ 10Overall
7/ 10Valuation
7/ 10Quality
6/ 10Fundamental
4/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 22.7P/E: 22.7 | P/B: 4.15
Growth
ModestSales CAGR — 3Y: 1% · 1Y: 11%
Profitability
High MarginROCE: 24.1% | ROE: 18%

Key Metrics

Valuation
PEG Ratio 2.84
Price / Sales 6.79x
Price / FCF 18.5x
Book Value ₹919
Margins & returns
Operating Margin 37%
Net Margin 28.6%
Return on Assets 14.9%

Frequently Asked Questions

MarketsPortfolioChart